Shenzhen International Medical Device Exhibition

The Exhibition Value of the China Medical Equipment Exhibition (CMEH) in Shenzhen

• One of the Largest and Most Influential Full-Industry-Chain Medical Device Events in South China: The China Medical Equipment Exhibition (CMEH), co‑organized by authoritative institutions such as the Shenzhen Medical Association, the Chinese Society for Medical Exchange, and the China Healthcare Industry Association, has been successfully held for dozens of editions since its inception. It stands as one of the most influential brand exhibitions in the medical device sector across South China. Through years of dedicated development and cultivation, the event has steadily expanded in scale and grown increasingly international, evolving from a regional platform for display and exchange into a B2B professional trade platform that connects global high‑quality resources, integrates upstream and downstream industries, and combines product showcases, technological exchanges, business negotiations, and trend announcements[citation:7]. The exhibition consistently aligns with national policy directions and industry development trends. With the deepening implementation of the “Healthy China 2030” initiative and the accelerated advancement of integrated healthcare within the Guangdong–Hong Kong–Macao Greater Bay Area, Shenzhen’s medical device industry is experiencing unprecedented opportunities. Leveraging Shenzhen’s strategic position as a national hub for the medical device industry, CMEH has become a key strategic gateway for gaining insights into market dynamics across South China and the nation, introducing cutting‑edge international technologies, and fostering collaborative innovation throughout the sector.
• A One‑Stop Platform Covering the Entire Industry Chain for Display and Procurement: The exhibition deeply integrates all key resources of the medical device industry, creating a comprehensive ecosystem that spans the entire value chain. Its exhibit portfolio comprehensively covers more than ten core application segments, including large‑scale medical imaging equipment (CT, DR, MRI), medical electronic instruments, smart healthcare and AI‑assisted diagnostic systems, operating room and emergency care devices, in vitro diagnostics (IVD) instruments and reagents, rehabilitation and nursing equipment along with home medical supplies, medical consumables and disinfection/protective products, genetic testing and life science instruments, as well as medical information management systems. Keeping pace with industry frontiers, the event places particular emphasis on the deep integration of disruptive technologies—such as artificial intelligence, big data, and the Internet of Things—with real‑world clinical applications. Cutting‑edge innovations like AI‑assisted diagnostics, telemedicine consultation systems, intelligent surgical robots, and digital therapeutics are prominently showcased, clearly outlining the technological pathways and future vision for the medical device industry’s evolution toward digitalization, intelligence, and precision.
• Precise Connection with Global Key Buyers and End‑User Healthcare Institutions: In 2025, the exhibition will reach a new record size, with an exhibition area of 100,000 square meters, bringing together over 2,000 exhibiting companies from around the world and attracting more than 60,000 professional visitors for onsite visits and procurement. The composition of the professional audience has been significantly optimized, with a growing share of high‑quality buyers, including decision‑makers responsible for equipment procurement at hospitals nationwide (including Grade III, Grade II, and specialized hospitals), medical device distributors and agents, overseas importers and trade representatives, as well as procurement managers from rehabilitation and elderly care facilities and community health service centers. Capitalizing on Shenzhen’s status as the nation’s top city in medical device output—exceeding RMB 100 billion in 2024—the exhibition highlights the innovative vitality and cluster advantages of Shenzhen and the Greater Bay Area in the high‑end medical device segment, providing exhibitors with a golden opportunity to directly engage end users and expand their market presence across China.
• Unique Value for Exhibiting Companies—The Preferred Platform for Building Brand Influence and Accelerating Technology Transfer: CMEH serves not only as a window for showcasing corporate image and flagship products but also as an ideal platform for manufacturers to broaden sales channels, unveil innovative breakthroughs, and seek research collaboration partners. In recent years, the Shenzhen Municipal Government has introduced a series of policies and measures to promote high‑quality development of the pharmaceutical and medical device industries, providing robust support for advanced medical device R&D and AI‑driven medical‑device innovation, thereby fostering a favorable ecosystem for industrial innovation. During the exhibition, numerous industry‑finance matchmaking sessions and industry‑university‑hospital collaborative innovation forums offer enterprises rare opportunities to connect with research institutes, access clinical resources, and translate innovative results into practical applications.
• A Vanguard for Technological Innovation and Industry Trends: CMEH consistently remains at the forefront of medical technology innovation, setting the direction for industry development. Hot topics featured at the exhibition—including AI‑assisted diagnostics, telemedicine, 5G‑enabled smart hospital solutions, surgical robots, and mixed‑reality medical imaging—highlight the latest achievements resulting from the deep integration of AI and medical devices. Leading industry experts, academicians, hospital administrators, and corporate executives gather to engage in high‑level dialogues on critical issues such as medical device registration and regulation, technology transfer, and clinical application innovation. Exhibiting companies can promptly obtain updates on industry policies, technical standards, and emerging trends, enabling them to accurately grasp market dynamics and seize technological leadership positions.
• Deep Integration of High‑Level Forums and Industry Resources: The synergy between exhibitions and conferences is a defining feature and core advantage of CMEH. Concurrently with the exhibition, dozens of high‑profile industry forums and technical seminars are held, covering topics such as interpretations of medical device innovation policies, trends in market access and tender procurement, industry‑university‑hospital collaborative innovation, and investment‑financing roadshows. Authoritative experts and opinion leaders from the National Health Commission, drug regulatory authorities, leading hospitals, and industry associations share cutting‑edge insights and conduct in‑depth discussions on pathways for industrial transformation and upgrading. Meanwhile, specially designated business negotiation zones and supply‑demand matchmaking services greatly enhance communication efficiency and the success rate of commercial cooperation between suppliers and buyers, facilitating the realization of intended orders and collaborative projects.
• Shenzhen’s Geographical and Policy Advantages: CMEH is held at two core venues—the Shenzhen Convention & Exhibition Center (Futian) and the Shenzhen International Convention & Exhibition Center (Bao’an New Hall)—fully leveraging Shenzhen’s strategic advantages as a pilot demonstration zone for socialism with Chinese characteristics, a core engine of the Guangdong–Hong Kong–Macao Greater Bay Area, and a key node along the Belt and Road Initiative. As one of China’s largest cities in terms of medical device industry scale and innovation capacity, Shenzhen exhibits a pronounced industrial agglomeration effect, nurturing a host of industry-leading enterprises such as Mindray, Lepu Medical, and MicroPort. Supported by Shenzhen’s open and inclusive culture of innovation and its globally connected international trade network, CMEH provides exhibitors with a strategic platform to deeply integrate into the Greater Bay Area’s medical industry value chain and connect with markets across China and along the Belt and Road.